SAB Biotherapeutics, Inc.SABSNASDAQ
Loading
Total Costs & Expenses Over TimeExpanding
Percentile Rank67
3Y CAGR-2.5%
5Y CAGR+7.1%
Year-over-Year Change
Total of all costs and expenses
3Y CAGR
-2.5%/yr
Annual compound
5Y CAGR
+7.1%/yr
Recent deceleration
Percentile
P67
Within normal range
vs 5Y Ago
1.4x
Solid growth
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $48.95M | +10.7% |
| 2024 | $44.23M | +9.7% |
| 2023 | $40.31M | -23.7% |
| 2022 | $52.82M | -28.9% |
| 2021 | $74.27M | +114.1% |
| 2020 | $34.68M | +186.3% |
| 2019 | $12.12M | - |